IM010 IDO1 and TNFRSF1B Knockout (KO) Pilot Part 1: MLD 50 analysis Part 2: Tissue collection for further analysis IDO1 HPAI H5N1 and SARS common bottleneck.

Slides:



Advertisements
Similar presentations
Lessons Learned from the Reconstruction of the 1918 Pandemic Adolfo García-Sastre, PhD Professor of Microbiology Mount Sinai School of Medicine.
Advertisements

Supplemental Figure 1 Tissue: ColorectumLungsVaginal wall Route: ICRIN IVAG IVAG (Depo) Dose: 2x10 9 5x10 8 1x Luc RLU (log10)
RESULTS: The inactivated vaccine provided mild protection of the ferrets from the SARS-CoV.
ACKNOWLEDGMENTS USD Animal Resource Center Jonathan A. McCullers (St. Jude Children’s Research Hospital) for providing viruses SD-BRIN Undergraduate Fellows.
The Immune System: Video Response Notes Part 1 Part 1 1.Which part of the body must the influenza-B virus reach in order to survive and multiply? 2.How.
Sendai virus: Illuminating parainfluenza virus dynamics in living animals Charles J. Russell, PhD postdoc: Crystal Burke, PhD Funding: NIAID R01AI
Project: Cellular microRNA profilings during the infections of the hepatitis C virus and the influenza A virus Yu Li Postdoc Fellow Katze Lab.
SARS (and a touch of Proteomics) Greg Zornetzer Project Summary 10/14/2008.
Deletion of Irf3 and Irf7 Genes in Mice Results in Altered Interferon Pathway Activation and Granulocyte-Dominated Inflammatory.
Volume 19, Issue 5, Pages (May 2017)
Copyright © 2008 American Medical Association. All rights reserved.
I. Mohammad*, K. Thieu, L. Fischer, P. Bittner-Eddy, M. Costalonga
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections  Chasity D. Andrews,
Immunological memory Topics Immune regulation  T cells
Body weight at harvest (g) Left kidney:body weight ratio (g/kg)
בטיחות בתעשייה בהיבט חברות הביטוח
Bridget A. Robinson, Timothy J. Nice  Immunity 
IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection  Hannah K. Bayes, Neil D. Ritchie, Christopher Ward,
Volume 85, Issue 5, Pages (May 2014)
Volume 23, Issue 6, Pages (May 2018)
Jennifer R. Hamilton, Gayathri Vijayakumar, Peter Palese  Cell Reports 
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease by Shan He, Fang.
Volume 15, Issue 1, Pages (January 2014)
Graft-Versus-Leukemia Effect and Graft-Versus-Host Disease Can Be Differentiated by Cytotoxic Mechanisms in a Murine Model of Allogeneic Bone Marrow Transplantation.
In vivo prophylactic and therapeutic efficacy of C12G6 in mice
Volume 22, Issue 7, Pages (July 2014)
(A) Weight loss curves following intranasal infection of different mouse groups with COBRA, seasonal, or pandemic influenza viruses. (A) Weight loss curves.
Volume 24, Issue 12, Pages (December 2016)
Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1  Richard Brans,
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Volume 26, Issue 2, Pages (February 2018)
DNSP16 mutation attenuates the virulence of a mouse-adapted MERS-CoV strain. dNSP16 mutation attenuates the virulence of a mouse-adapted MERS-CoV strain.
Protection from influenza virus challenge.
Volume 42, Issue 4, Pages (April 2015)
A Mouse Model of Zika Virus Pathogenesis
Viperin−/−mice have an increased IFNγ Th1 response.
TAM Receptors Are Not Required for Zika Virus Infection in Mice
Volume 19, Issue 2, Pages (February 2016)
Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection  Xinying Tang, Hongbo Zhang,
Volume 21, Issue 6, Pages (November 2017)
Dose Concentration (mg/kg)
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections  Chasity D. Andrews,
Volume 22, Issue 1, Pages (January 2014)
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Volume 9, Issue 6, Pages (June 2004)
Comparison of therapeutic efficacies of C12G6 and other bnAbs in mice
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models  Fabrice Le Boeuf, Simon Gebremeskel,
Genotype and Treatment Change in Weight (grams)
HECTD2 knockdown ameliorates Pseudomonas-induced lung injury in vivo
SARS-CoV and IFN: Too Little, Too Late
Hannah Chen, Padma Sampath, Weizhou Hou, Stephen H. Thorne 
Fig. 4. Efficacy of C12G6 compared with and in combination with oseltamivir in mice. Efficacy of C12G6 compared with and in combination with oseltamivir.
Melissa B. Uccellini, Adolfo García-Sastre  Cell Reports 
Volume 24, Issue 10, Pages (October 2016)
Volume 13, Issue 7, Pages (November 2015)
Fig. 1. IL-31 and IL-31R mRNA expression was upregulated in the asthma mouse model. IL-31 and IL-31R mRNA expression was upregulated in the asthma mouse.
Volume 43, Issue 4, Pages (October 2015)
Volume 11, Issue 10, Pages (June 2015)
Volume 20, Issue 4, Pages (April 2012)
HECTD2 knockdown ameliorates Pseudomonas-induced lung injury in vivo
Volume 17, Issue 3, Pages (March 2015)
Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice  Jun Li, Kenrick Semple, Woong-Kyung Suh, Chen Liu, Fangping.
A B Supplemental Figure 1. Growth of secondary (left-leg) tumors and lack of change in body weight in a Lewis lung carcinoma mouse model after treatments.
Volume 21, Issue 3, Pages (March 2017)
Volume 118, Issue 6, Pages (June 2000)
Volume 23, Issue 6, Pages (May 2018)
Volume 7, Issue 2, Pages (February 2003)
Fig. 2 NDR2-deficient mice are more vulnerable to RNA viral infection.
Activity of a chemically modified miR-21 inhibitor in human bladder cancer xenografts. Activity of a chemically modified miR-21 inhibitor in human bladder.
In vivo prophylactic and therapeutic efficacy of C12G6 in mice
Presentation transcript:

IM010 IDO1 and TNFRSF1B Knockout (KO) Pilot Part 1: MLD 50 analysis Part 2: Tissue collection for further analysis IDO1 HPAI H5N1 and SARS common bottleneck Primarily DC and macrophage May regulate type I IFN expression May facilitate expansion of Treg cells TNFRSF1B HPAI H5N1 and SARS common eigengene Role in apoptosis

MLD 50 Analysis Inoculation 3 mice per inoculation group 0.1, 1, 10 and 100 PFU dosages Measurements Time frame: 14 days MLD 50 calculation (Reed and Muench method) Survival (mean time to death) Group body weight changes

GenotypeMLD 50 Wild-type0.18 PFU IDO1 KO0.56 PFU TNFRSF1B3.16 PFU Mouse Lethal Dose 50 (MLD 50 ) for VN1203 Wild-type, IDO1 KO and TNFRSF1B KO Ratio of KO to Mock: Note that this is not a hugely impressive difference in MLD50.

MLD 50 Survival and Weight Loss Data: 1 PFU Wild-type, IDO1 KO and TNFRSF1B KO All wild-type died Two IDO1 KO died All TNFRSF1B KO lived Rapid weight loss in wild-type Intermediate weight loss in IDO1 KO No weight loss in TNFRSF1B KO

No differences in weight loss or survival at higher dosages (10 and 100 PFU) Subtle differences at lower dosage (0.1 PFU)

MLD 50 Mean Time to Death per Dosage Wild-type, IDO1 KO and TNFRSF1B KO

Tissue Harvest Groups Inoculation 3 mice per inoculation group, mock and VN PFU dosage Measurements Time frame: 6 days Harvest tissues on day 2 and before death (days 5-6) Body weights Survival Lung titer RNA for microarray (optional) Histopathology (optional)

Tissue Harvest Groups Weight Loss Dosage: 1000 PFU Wild-type, IDO1 KO and TNFRSF1B KO Survival Wild-type: All animals died on day 5; lung tissues harvested only on day 2  IDO1 KO: All animals euthanized on day 6; lung tissues harvested on days 2 and 6 TNFRSF1B KO: One animal died between days 5-6 and 2 were euthanized on day 6; lung tissues harvested on days 2 and 6 Longer survival and significantly reduced body weight loss for both KO genotypes

Tissue Harvest Groups Virus titer Dosage: 1000 PFU Wild-type, IDO1 KO and TNFRSF1B KO No differences in virus titers were observed at the early time point.

For Comparison and Perspective… Wild-type mice infected with VN1203-wild type, VN1203-NS1trunc124 or VN1203-PB1-F2del NS1-trunc PFU PB1-F2del 1000 PFU

For Comparison and Perspective… Wild-type mice infected with VN1203-wild type, VN1203-NS1trunc124 or VN1203-PB1-F2del NS1-trunc PFU PB1-F2del 1000 PFU